Bosutris Tablets contain Bosutinib, an anti-cancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is prescribed for certain patients diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), a type of blood cancer.
Bosutinib works by targeting abnormal proteins responsible for the uncontrolled growth of cancer cells. It helps slow down the multiplication of these cells and manage disease progression.
For pharmaceutical buyers, importers, distributors and healthcare procurement professionals in the United States, understanding the product composition, strengths, therapeutic applications and safety information is important when evaluating Bosutinib-based medicines.
Bosutris Tablets – Product Details
Brand Name: Bosutris Tablets
Active Ingredient: Bosutinib
Therapeutic Category: Antineoplastic Medicine
Drug Class: Tyrosine Kinase Inhibitor
Dosage Form: Oral Tablets
Available Brand Strengths: 100 mg, 400 mg and 500 mg
Prescription Status: Prescription-only medicine
Product strengths and packaging should always be verified against the manufacturer's current product documentation.
Uses and Medical Applications of Bosutris Tablets
Bosutris Tablets are prescribed for the management of specific forms of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
Bosutinib works by inhibiting abnormal BCR-ABL tyrosine kinase activity, which plays an important role in the development of this blood cancer.
Depending on the applicable product authorization and prescribing information, bosutinib may be used in adults with newly diagnosed chronic-phase Ph+ CML or patients whose disease has not responded adequately to, or who cannot tolerate, previous treatment.
Treatment decisions depend on the patient's medical condition, disease phase, previous therapies and specialist assessment.
Potential Side Effects of Bosutris Tablets
Like other targeted cancer medicines, Bosutinib may cause side effects. Commonly reported adverse reactions include:
Diarrhoea
Nausea and vomiting
Abdominal pain
Headache
Fatigue
Skin rash
Respiratory tract infections
Changes in liver enzyme levels
Reduced blood cell counts
Increased creatinine levels
Important safety information: Bosutinib can also cause serious gastrointestinal, liver, kidney, cardiovascular and blood-related complications. Patients require regular medical monitoring, including blood counts, liver function and kidney function assessments.
Seek immediate medical attention for severe symptoms, unusual bleeding, breathing difficulties or signs of serious infection.
Bosutinib should only be used under the supervision of a qualified oncologist. Patients should not change their dosage or discontinue treatment without medical advice.
Pharmaceutical Exporter from India – Cordium Pharmaceuticals Pvt. Ltd.
Cordium Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical supplier and exporter serving international pharmaceutical procurement requirements.
We welcome enquiries from pharmaceutical distributors, importers, wholesalers and institutional procurement teams interested in exploring pharmaceutical sourcing opportunities from India.
For Bosutris Tablets and other oncology pharmaceutical product enquiries, buyers can contact our team to discuss product specifications, available strengths, packaging information, documentation and export requirements.
For the US market, product-specific FDA authorization, applicable import requirements, prescription regulations and distribution permissions must be verified before commercial supply. Enquiry acceptance does not imply US marketing authorization.
Frequently Asked Questions (FAQs)
1. What is the active ingredient in Bosutris Tablets?
Bosutris Tablets contain Bosutinib, a tyrosine kinase inhibitor used in the treatment of certain forms of chronic myeloid leukemia.
2. What are Bosutris Tablets used for?
They are prescribed for eligible patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
3. What are the common side effects of Bosutris?
Common side effects include diarrhoea, nausea, vomiting, abdominal pain, fatigue, headache and changes in blood counts or liver enzymes.
4. Can Bosutris Tablets be purchased without a prescription in the USA?
No. Bosutinib is a prescription cancer medicine and requires appropriate medical supervision and a valid prescription.
5. How can pharmaceutical buyers enquire about Bosutinib Tablets from India?
International buyers can contact Cordium Pharmaceuticals Pvt. Ltd. for product availability, specifications, export documentation and commercial enquiries, subject to applicable regulatory requirements.
Disclaimer: This content is intended for general pharmaceutical information and is not a substitute for professional medical advice. Always consult the official prescribing information and a qualified healthcare professional before using Bosutinib.
Bosutinib works by targeting abnormal proteins responsible for the uncontrolled growth of cancer cells. It helps slow down the multiplication of these cells and manage disease progression.
For pharmaceutical buyers, importers, distributors and healthcare procurement professionals in the United States, understanding the product composition, strengths, therapeutic applications and safety information is important when evaluating Bosutinib-based medicines.
Bosutris Tablets – Product Details
Brand Name: Bosutris Tablets
Active Ingredient: Bosutinib
Therapeutic Category: Antineoplastic Medicine
Drug Class: Tyrosine Kinase Inhibitor
Dosage Form: Oral Tablets
Available Brand Strengths: 100 mg, 400 mg and 500 mg
Prescription Status: Prescription-only medicine
Product strengths and packaging should always be verified against the manufacturer's current product documentation.
Uses and Medical Applications of Bosutris Tablets
Bosutris Tablets are prescribed for the management of specific forms of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
Bosutinib works by inhibiting abnormal BCR-ABL tyrosine kinase activity, which plays an important role in the development of this blood cancer.
Depending on the applicable product authorization and prescribing information, bosutinib may be used in adults with newly diagnosed chronic-phase Ph+ CML or patients whose disease has not responded adequately to, or who cannot tolerate, previous treatment.
Treatment decisions depend on the patient's medical condition, disease phase, previous therapies and specialist assessment.
Potential Side Effects of Bosutris Tablets
Like other targeted cancer medicines, Bosutinib may cause side effects. Commonly reported adverse reactions include:
Diarrhoea
Nausea and vomiting
Abdominal pain
Headache
Fatigue
Skin rash
Respiratory tract infections
Changes in liver enzyme levels
Reduced blood cell counts
Increased creatinine levels
Important safety information: Bosutinib can also cause serious gastrointestinal, liver, kidney, cardiovascular and blood-related complications. Patients require regular medical monitoring, including blood counts, liver function and kidney function assessments.
Seek immediate medical attention for severe symptoms, unusual bleeding, breathing difficulties or signs of serious infection.
Bosutinib should only be used under the supervision of a qualified oncologist. Patients should not change their dosage or discontinue treatment without medical advice.
Pharmaceutical Exporter from India – Cordium Pharmaceuticals Pvt. Ltd.
Cordium Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical supplier and exporter serving international pharmaceutical procurement requirements.
We welcome enquiries from pharmaceutical distributors, importers, wholesalers and institutional procurement teams interested in exploring pharmaceutical sourcing opportunities from India.
For Bosutris Tablets and other oncology pharmaceutical product enquiries, buyers can contact our team to discuss product specifications, available strengths, packaging information, documentation and export requirements.
For the US market, product-specific FDA authorization, applicable import requirements, prescription regulations and distribution permissions must be verified before commercial supply. Enquiry acceptance does not imply US marketing authorization.
Frequently Asked Questions (FAQs)
1. What is the active ingredient in Bosutris Tablets?
Bosutris Tablets contain Bosutinib, a tyrosine kinase inhibitor used in the treatment of certain forms of chronic myeloid leukemia.
2. What are Bosutris Tablets used for?
They are prescribed for eligible patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
3. What are the common side effects of Bosutris?
Common side effects include diarrhoea, nausea, vomiting, abdominal pain, fatigue, headache and changes in blood counts or liver enzymes.
4. Can Bosutris Tablets be purchased without a prescription in the USA?
No. Bosutinib is a prescription cancer medicine and requires appropriate medical supervision and a valid prescription.
5. How can pharmaceutical buyers enquire about Bosutinib Tablets from India?
International buyers can contact Cordium Pharmaceuticals Pvt. Ltd. for product availability, specifications, export documentation and commercial enquiries, subject to applicable regulatory requirements.
Disclaimer: This content is intended for general pharmaceutical information and is not a substitute for professional medical advice. Always consult the official prescribing information and a qualified healthcare professional before using Bosutinib.
Keywords
